Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04407195 · ClinicalTrials.gov registry record
COVID-19 and Mental Health
A clinical trial, sponsored by Northeastern University.
- Completed
- Registry status
- 400
- Enrollment target
NCT04407195: Completed study, sponsored by Northeastern University.
NCT04407195 is a clinical trial that has completed, run by Northeastern University. The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04407195 has completed, sponsored by Northeastern University.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
Study Summary
The overall objective of this study is to assess the enormity of mental health outcomes among healthcare providers (nurses and physicians) exposed to COVID-19 during the time of the pandemic in the United States, specifically targeting those areas most effected.
Primary Outcome
The Impact of Event Scale - Revised (IES-R). IES-R is a 22-item scale with possible scores ranging from 0 - 88. Scores higher than 24 are of concern indicating possible health and well-being consequences.
Interventions
- OTHER Exposure to the SARS-CoV-2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2020-06-01 |
| Est. Completion | 2021-06-01 |
What the finished NCT04407195 record still lists
NCT04407195 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Exposure to the SARS-CoV-2 is the first listed.
NCT04407195 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04407195 about?
NCT04407195 is a clinical study titled "COVID-19 and Mental Health". The overall objective of this study is to assess the enormity of mental health outcomes among healthcare providers (nurses and physicians) exposed to COVID-19 during the time of the pandemic in the United States, specifically targeting those areas most effected.
What is the current status of trial NCT04407195?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2020-06-01. Estimated completion is 2021-06-01.
What interventions are being tested in trial NCT04407195?
The interventions under investigation include: Exposure to the SARS-CoV-2 (OTHER).
Who is sponsoring clinical trial NCT04407195?
This trial is sponsored by Northeastern University, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI